Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
29.10
+0.10 (0.34%)
At close: Jun 12, 2026, 4:00 PM EDT
29.68
+0.58 (1.99%)
After-hours: Jun 12, 2026, 5:09 PM EDT
Neurogene Employees
Neurogene had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year.
Employees
131
Change (1Y)
24
Growth (1Y)
22.43%
Revenue / Employee
n/a
Profits / Employee
-$752,962
Market Cap
459.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Jun 30, 2023 | 82 | - | - |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Arvinas | 246 |
| 4D Molecular Therapeutics | 196 |
| Sutro Biopharma | 133 |
| Kyverna Therapeutics | 130 |
| C4 Therapeutics | 104 |
| Assembly Biosciences | 73 |
| Prothena Corporation | 67 |
NGNE News
- 4 days ago - Neurogene completes dosing in Embolden trial of NGN-401 - TheFly
- 4 days ago - Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome - Business Wire
- 9 days ago - Neurogene Transcript: AGM 2026 - Transcripts
- 9 days ago - Neurogene initiated with a Buy at Rodman & Renshaw - TheFly
- 10 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Neurogene reports Q1 EPS ($1.39), consensus ($1.27) - TheFly
- 4 weeks ago - Neurogene Reports First Quarter 2026 Financial Results and Highlights Recent Updates - Business Wire
- 4 weeks ago - Neurogene Quarterly report: Q1 2026 - Filings